Aby Buchbinder
2012
In 2012, Aby Buchbinder earned a total compensation of $584.5K as Former Vice President, Clinical Development at Enzon Pharmaceuticals, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $85,794 |
|---|---|
| Option Awards | $27,138 |
| Salary | $350,181 |
| Stock Awards | $111,385 |
| Other | $10,045 |
| Total | $584,543 |
Buchbinder received $350.2K in salary, accounting for 60% of the total pay in 2012.
Buchbinder also received $85.8K in non-equity incentive plan, $27.1K in option awards, $111.4K in stock awards and $10K in other compensation.
Rankings
In 2012, Aby Buchbinder's compensation ranked 8,229th out of 11,487 executives tracked by ExecPay. In other words, Buchbinder earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,229 out of 11,487 | 28th |
Division Manufacturing | 2,975 out of 4,253 | 30th |
Major group Chemicals And Allied Products | 789 out of 1,198 | 34th |
Industry group Drugs | 564 out of 920 | 39th |
Industry Biological Products, Except Diagnostic Substances | 93 out of 160 | 42nd |
Source: SEC filing on April 16, 2014.
Buchbinder's colleagues
We found five more compensation records of executives who worked with Aby Buchbinder at Enzon Pharmaceuticals in 2012.
2012
Ana Stancic
Enzon Pharmaceuticals
Chief Financial Officer
2012
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2012
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2012
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2012
Timothy Daly
Enzon Pharmaceuticals